PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
(+)-tartaric acid 201-766-0 87-69-4 - - 6 - - - - - - Details
(+-)-(3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan 948-069-4 - - - 1 - - - - - - Details
(+/-) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate
PANTERA; QUIZALOFOP-P-TEFURYL
414-200-4 200509-41-7 - - - - - 1 - - - Details
(+/-) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)pent-4-en-2-ol
POLYSANTOL
411-580-3 107898-54-4 - - 1 - - - - - - Details
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 214-619-0 1166-46-7 - - - 1 - 1 - - - Details
(1-hydroxyethylidene)bisphosphonic acid, sodium salt 249-559-4 29329-71-3 - - 2 - - - - - - Details
(1-methylethyl)-1,1'-biphenyl 247-156-8 25640-78-2 1 - 1 - - - - - - Details
(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)propyl-2-ammonium (1R, 5S)-5-(dimethylphenylsilyl)-2-(hydroxymethyl)cyclopent-2-ene-1-carboxylate 445-910-2 649761-22-8 - - 1 - - - - - - Details
(1R,2S,5R)-5-methyl-2-(propan-2-yl)-N-[2-(pyridin-2-yl)ethyl]cyclohexanecarboxamide 700-097-6 847565-09-7 - - 1 - - - - - - Details
(1S)-3,7,7-trimethylbicyclo[4.1.0]hept-3-ene 207-856-6 498-15-7 - - 1 - - - - - - Details
(1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate 431-700-8 259823-90-0 - - 2 - - - - - - Details
(1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene 232-077-3 7785-26-4 - - 2 - - - - - - Details
(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-2,1-ethanediyl triacrylate 254-843-6 40220-08-4 - - 1 - - - - - - Details
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate;reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate 442-300-8 - - - 2 - - - - - - Details
(2-hydroxyethyl)ammonium mercaptoacetate 204-815-4 126-97-6 - - 2 - - - - - - Details
(2-methoxymethylethoxy)propanol 252-104-2 34590-94-8 - - 2 - - - - - - Details
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate;bifenthrin (ISO) 617-373-6 82657-04-3 - - - - - 1 - - - Details
(2E)-2-(4-methylbenzylidene)heptanal 821-749-7 154581-97-2 - - 1 - - - - - - Details
(2E)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol 701-122-3 106185-75-5 - - 5 - - - - - - Details
(2E)-2-methyl-3-phenylacrylaldehyde 701-219-0 15174-47-7 - - 1 - - - - - - Details
(2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole - 1417782-03-6 - - - - - 1 - - - Details
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[( 1H-1,2,4-triazol-1-yl)methyl]oxirane 406-850-2 133855-98-8 - - - - - 1 - - - Details
(3-chloropropyl)diethoxymethylsilane 236-828-6 13501-76-3 - - 1 - - - - - - Details
(3-chloropropyl)dimethoxymethylsilane 242-056-0 18171-19-2 - - 3 - - - - - - Details
(3-chloropropyl)triethoxysilane 225-805-6 5089-70-3 - - 2 - - - - - - Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.